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The previous studies from this laboratory of meningococcus infec- 
tion,  particularly those on the  carrier problem  (1),  had left certain 
important questions unanswered which from their nature could best 
be investigated during a  localized epidemic.  Among such questions 
was  the duration of the  carrier state  when  this  was  due  to known 
"epidemic" or disease-producing strains  as contrasted with the pre- 
sumably  saprophytic  or  avirulent  strains  met  with  in  the  case  of 
groups of healthy persons studied and reported in the earlier paper 
(1).  Further, the whole question of the exact nature of the carrier 
state in the case of the menlngococcus was doubtful.  Was it to be 
looked upon as a  true infection of the body by the organisms, albeit 
more or less localized to the nasopharyngeal mucous membrane, or 
was the relationship between meningococcus and host of much less 
intimate nature involving no reaction of the host to  the organism? 
It  was  certainly  desirable  to  obtain  closer  information  as  to  the 
virulence of strains, epidemic or sporadic, from the spinal fluid or the 
nasopharynx,  than  had  hitherto  been  available.  The  latter  inves- 
tigation depended, of course, on the introduction and perfection of a 
suitable test for meningococcus virulence in experimental animals. 
With the unanswered questions in mind an invitation from Colonel 
Addison  Davis  of  the  6th  Corps  Area  Headquarters,  Chicago,  to 
participate in the investigation of an outbreak of cerebrospinal menin- 
gitis in a  Civilian Conservation Corps lumber camp in Wisconsin was 
gratefully accepted.  1 
1 My thanks are due to all those with whom I worked whose efforts made such 
detailed work possible, especially to  Colonel Addison Davis,  to  Major  A.  P. 
Hitchens, to Lieutenant B. L. Camp, to Lieutenant T. Ennis, to Dr. W. D. StovaU, 
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Investigation commenced on Feb. 22, 1934, at C.C.C. Camp Rusk, Wisconsin, a 
camp with a personnel of 215, situated 25 miles from the nearest town.  The popu- 
lation of the latter was approximately 3,500.  The history of the epidemic  up to that 
time was as follows: On Nov. 25, 1933, a case of cerebrospinal meningitis occurred 
in a  C.C.C. worker.  Since that time 5 other cases had occurred in the camp and 
8 in the civilian population of about 6,000 persons.  In point of time the cases had 
been well scattered, occurring every 1 or 2 weeks between Nov. 25 and the date that 
the investigation was commenced.  The camp had been intermittently in quaran- 
tine, but before this was first applied and at intervals thereafter contact between 
the camp and the civilian population had been very close.  No strains of menin- 
gococci had been recovered by the military authorities working with  a  mobile 
laboratory, but Dr. Stovall of the Wisconsin State Board of Health had isolated 
2 strains and identified them as "Type III" meningococci.  During the 32  days 
spent at the camp by the present author only 2 fresh cases occurred.  Any prob- 
lems, therefore, which were connected with cases of the frank disease itself could 
not be investigated and attention was paid to the carrier situation. 
In all, 72 Type I-III and 23 Type II and 2 Type VII carriers were found in the 
camp.  A few were found among the civilianpopulationbut,  unfortunately, circum- 
stances did not allow a  detailed examination for carriers outside the camp.  The 
work in the camp was necessarily confined, for the most part, to the study of the 
carriers, the approximate degree of their infection and the length of duration of the 
carrier state.  This was supervised personally for a  little over 4  weeks and was 
then carried on for another 6 weeks first by Major A. P. Hitchens and later by 
Dr. Ernest Q. King, both of whom have kindly given permission for the inclusion 
of their records in this paper. 
In addition to the work carried on at the camp itself, cultures of carrier strains 
and samples of blood from the carriers were obtained and were brought back to the 
laboratories at The Rockefeller Institute where further investigations were made. 
It is realized that  the results with the  carrier and case strains, especially with 
regard to the virulence tests, are somewhat unsatisfactory on account of the inter- 
val elapsing between the isolation of the strain and the carrying out of the virulence 
test.  The arrangements made, however, were the best possible under the circum- 
stances. 
RESULTS 
Of the 94  carriers 71  carried Type I,  22  carried Type II  and  1 
carried Type VII; one was a Type I  carrier that once showed a Type 
II, and another, that once showed a Type VII; one, a Type II carrier 
once showing Type I; and one carrier showed Type II and Type VII 
to Dr. W. Smith, to Dr. L. M. Lundmark and to C.C.C. enrollees  Edmund Malecki 
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11 Type 
4 Type 
6 Type 
8Type 
20 Type 
4 Type 
5 Type 
4 Type 
each once.  This gives the high rate of 33.5 per cent Type I  carriers 
and 10.7 per cent Type II.  As far as throwing light on the duration 
of the cartier state is concerned, the results are unsatisfactory.  Owing 
to the need for closing the camp as soon as possible,  the authorities 
transferred  the  men or  sent  them home very early--in  some  cases 
even when the last swab had been positive for meningococci.  Many 
other carriers  were still positive, or had been  so recently, when the 
investigation closed.  As has been shown elsewhere (1), carriers  may 
still be found positive even after 4]  months of  negative  swabbings. 
This being so, it could not, of course, be said that any of these carriers 
cleared  up,  the  total  duration  of  the  investigation  being  only  2½ 
months.  It seems probable that the clearing up of the  carrier state 
should be based on negative weekly swabs lasting over a period of at 
least  2  or 3 months, since 3  consecutive negative weekly  swabbings 
are of little value when assessing the normal duration of the carrier 
condition  (1).  Even if,  however, the basis of 3  consecutive weekly 
swabbings should be adopted as indicating a cure, the results obtained 
in the present investigation were unsatisfactory.  Thus:-- 
I  ~ carriers were still positive when swabbing ceased. 
II  J 
I  1 carriers showed only 1 negative culture when swabbing ceased. 
II  J 
I  /  carriers showed only 2 negative cultures when swabbing ceased. 
II  J 
I  ~ carriers showed only 3 negative cultures when swabbing ceased and 
III  the period from the last positive to the last negative was less than 
3 weeks. 
It is clear, therefore, that 42 out of 72 Type I  carriers and 20 out of 
23 Type II carriers, on any of the criteria accepted for the "cure" of 
meningococcus carriers,  were  still  potentially  affected when  the  in- 
vestigation ended. 
It is with these considerations in mind that the table  showing the 
duration  of  the  carrier  state  during  epidemic  conditions  at  Camp 
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the  basis  of  "cure"  constituted by  3  consecutive weekly negative 
swabs,  37.5 per cent of Type I  carriers lasted 4  weeks or less,  33.5 
per cent lasted 5 weeks or over and 29.3 per cent were still potentially 
affected when last seen, having lasted 4 weeks or less up to that time. 
With the Type II carriers 13 per cent lasted 4 weeks or less, 4.3 per 
cent (this represents only 1 case) 5 weeks or more and 82.7 per cent 
were still potentially affected when last seen. 
TABLE  I 
Duration of carrier state  Type I carriers  Type II carriers 
days 
1 
1++ 
wks. 
1++ 
2 
2++ 
2½ 
3 
3++ 
4 
5 
5++ 
6++ 
7++ 
7½++ 
8 
8½++ 
9++ 
il++ 
16 
7 
6 
4 
1 
3 
10 
1 
2 
5 
7 
2 
2 
1 
3 
1 
1 
22,2  2 
9,7  14 
4 
8.3 
5.6  1 
1.4  1 
4.2 
14.0 
1.4 
2.8 
7.0 
9.7 
2.8 
2.8 
1.4 
4.2 
1.4 
1.4  1 
8.7 
~.9 
17.4 
4.3 
4.3 
4.3 
+ +  =  negative swabbings not obtained 3 times at weekly intervals in these 
carriers. 
Even on this basis, then, the number of Type I  carriers remaining 
positive for over 5 weeks was high.  The figure was comparable to 
that recorded by Flack (2).  He showed that 47.59 per cent of contact 
carriers lasted over 4  weeks and  52.41  per cent under 4  weeks.  In 
non-contacts the  average duration was  shorter and the figures were 
27.77 per cent and 72.23 per cent respectively.  The experience in this 
laboratory has been contrary to that of Flack in that non-contacts, 
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It is believed that the average duration of the carrier state as demon- 
strated at Camp Rusk or as recorded anywhere in the literature is put 
somewhat, and probably much, too low.  In the case of the Camp 
Rusk  epidemic another  variable  factor  occurred in  the  change  of 
personnel which took place twice during the investigation.  Although 
exactly the same equipment be available and the same technique be 
adopted in each case, there is no doubt that the personal element is 
very great in any method used for the detection of meningococcus 
carriers.  The individual who has had several years of close experience 
with this work will inevitably find a  higher percentage of positive 
throat plates than anyone coming to the task relatively inexperienced. 
It is undoubtedly true that the greater number of these carriers at 
Camp Rusk, carrying typical Type I  or Type II (epidemic) strains, 
did not give such constantly positive plates as had been usual amongst 
the non-contact group carrying, for the most part, strains not identical 
with Gordon's 4  types; that is, what might be called non-epidemic 
strains (1).  This fact, added to the fact that the demonstrable carrier 
duration with epidemic strains was relatively short, might be taken in 
support of the theory that virulent strains of meningococci are carried 
for  only  short  periods  as  compared  with  the  comparatively non- 
virulent or even saprophytic strains.  This would be in accord with 
the known facts with regard to pneumococcus carriers (3-5).  On the 
other hand, it must be borne in mind that laboratory conditions at the 
C.C.C. camp were by no means ideal and that this fact together with 
the changing personnel would undoubtedly affect the work adversely 
and produce a higher percentage of apparently negative throat cultures 
than was actually the case.  The question of duration of the carrier 
state  when  virulent  (epidemic)  typical  meningococcus strains  are 
concerned, which is  an  important  unsolved problem,  must  still  be 
regarded as sub judice. 
Virulence of Strains for Mice 
A study of the virulence of meningococcus strains gathered during 
an epidemic depended, of course, entirely on the existence of a suitable 
animal test.  Such a  test had not been available, at least in small 
laboratory animals, until Miller (6) described his method of producing 
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suspensions.  A  study of this method confirmed all  that  Miller had 
claimed for it and showed that, at least in certain susceptible breeds 
of mice, it gave consistent results which could be used as a  basis for 
the titration of meningococcal virulence.  2 
The following has been adopted as the standard method for the titration of the 
virulence of meningococcus strains.  A 6 per cent solution of hog's gastric mucin 
at pH 7.4 is prepared according to the method described by Miller.  The strain 
to be investigated is grown for 16 to 18 hours on a  10 per cent rabbit's blood 
pneumococcus agar.  It is then washed off in normal saline and the saline suspen- 
sion diluted until a standard suspension, containing 2,000,000,000 organisms to the 
cubic centimeter, is obtained.  Dilutions of this suspension, each 1 in 10, are made 
in the 6 per cent mucin.  For most strains it has been found that dilutions from 
10  -s to 10  -e are sufficient for the titration of virulence.  A cubic centimeter of 
10  -~ dilution will contain 20,000,000 organisms  and a cubic centimeter of 10  -e, 
2,000 organisms.  1 cc. of the 6 per cent mucin suspension of each dilution is in- 
jected intra-abdominally into at least  2  mice.  It is  important  that  all  steps 
involving the meningococci, from the time they are washed from the plate until 
the inoculation is made, be carried out as rapidly as possible.  The lowest dilution 
at which all mice die is taken as the end-point, but any deaths beyond this point 
are indicated by a  +  sign.  Thus, if all mice die at 10  -5 and only I out of 2 or 3 at 
10  -5, the virulence is given as 10-5+.  It has been found that in order to obtain 
consistent results the susceptible breed of white-face mice is the most satisfactory 
of those yet tested. 
Using this method of virulence titration, 34 strains isolated from the 
carriers at  Camp  Rusk were tested after they were brought back to 
the  laboratory at  the  Institute.  Of these  strains,  14  were  Type I, 
12 Type II, 3'Type VII and 5 were Neisseria catarrhalis strains isolated 
from carriers.  Table II shows  the mouse virulence of these strains. 
It is clear from Table II that the majority of Type I  strains had a 
high virulence, 78.6 per cent showing a  virulence of 10  -5 or greater. 
There is no explanation why one Type I  strain should have failed to 
kill at all.  At the time it was titrated it had been isolated from the 
nasopharynx 24 days, and the average elapsed time for Type I  strains 
was  24.7  days with a  spread of from 15  days  (strain with virulence 
10  -5 +) to 36 days  (strain with virulence  10  -5 +).  The virulence of 
Not all batches of mucin obtained from commercial sources are Mike in their 
power  of enhancing  the  pathogenic activity of meningococcus  strains.  Some 
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the  Type II  strains  is  significantly less  than  that  of  the  Type  I. 
66.7 per cent of Type II strains have a virulence of 10  -~ +  and only 
1 strain (out of 12) has a virulence greater than this.  The virulence 
of the atypical Type VII strains was much less,  the most virulent 
strain being only 10  -2 +, while the strains of N. catarrhalis were com- 
pletely avirulent with the exception of one that killed at 10  -3. 
The high virulence of Type I  strains and the moderately high but 
lesser virulence of Type II strains are interesting.  It seems probable 
that the epidemic was produced by Type I  or Group I-III  strains. 
TABLE  II 
Virulence 
10-6 
10-s+ 
10-6 
10-4 
10-s+ 
10-a 
10-~+ 
10-2 
None 
Average time between isola- 
tion and testing of strains, 
days. 
Type I 
Per 
cent 
28.6 
28.6 
21.4 
14.3 
7.1 
24".7 
Type II 
Per 
cent 
i 
1  8.3 
8  66.7 
1  8.3 
1  8.3 
!  8.3 
21.0 
Type  VII  N. catarr~is 
Strains  i Strains  Strains  Per  i Strains 
cent 
t 
1  33.3 
1  33.3 
1  33.3 
29.7 
Per • 
cent 
I  20.0 
4  80.0 
27.8 
In favor of this are the following facts.  Both cases occurring during 
the personal investigation of the epidemic were Type I cases and one 
of them occurred in a known Type I carrier; Dr. StovaU had isolated 
2 Type III strains at an earlier date; one of the cases proved later to 
be a Type I carrier, being found positive once 5 months after the onset 
of the meningitis (this is of doubtful significance;  it may have been 
only a  new infection from contact with other carriers); the Type I 
carrier rate was 33.5 per cent which is well over the "explosion point" 
of 20 per cent.  On the other hand, it is possible that some cases may 
have been due to Type II organisms.  One case, that was seen very 
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I  organisms in the nasopharynx but showed a Type II strain once 40 
days after the onset of the disease; a  specimen of spinal fluid taken 
from a  civilian  case at the height  of the illness proved later  to have 
precipitinogens  which reacted moderately with Type II antimeningo- 
coccus serum  (unfortunately  no  strain  had  been  isolated  from  this 
patient  at the time she was sick but her blood, taken  3  weeks after 
the onset of the disease  , showed Type II  agglutinins  and protective 
antibodies  as  described  below); finally,  the  Type  II  carrier  rate  of 
10.7 per cent, while not very high,  is a high normal figure and might 
be compatible with the appearance of a few Type II cases.  The rela- 
tive virulence of the 2  types as isolated from carriers  might  also be 
taken  as suggestive of a  main  Type I  epidemic with  some Type II 
cases. 
The Nature of the Carrier State 
The  nature  of  the  carrier  state  in  meningococcus  infections  has 
stirred  up  much  controversy.  The  fundamental  question  at  issue 
is whether this can be looked upon as a true infection or not.  Are we 
to believe that the meningococcus on being implanted on the mucous 
surface of the nasopharynx causes any reaction within the host either 
local in the way of inflammation  or general in the way of serological 
and  other  changes,  or are we  to look on  the  meningococcus  carrier 
state as a  more or less passive symbiotic relationship  much like that 
of the Staphylococcus  albus on the skin or DSderlein's bacillus in the 
vagina?  Although some investigators (7) have claimed that meningo- 
cocci usually, if not invariably,  cause an inflammation  of the mucosa 
of the nasopharynx,  and  although  reports of epidemics of meningo- 
coccal nasopharyngitis  preceding  or  running  concurrently  with  epi- 
demics of meningitis  exist, nevertheless these are usually discounted 
and apparently  the feeling of the majority of workers, whether pub- 
fished or not,  is that  the meningococcus produces no reaction in the 
mucosa and that  the carrier  state in this disease is not to be looked 
upon as an infection. 
In the case of other organisms carried,  as is the meningococcus, in 
the nasopharynx,  there is  the same lack of unanimity  of opinion  as 
to the precise status of the carrier condition.  With the pneumococcus, 
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carrier state is  in  the nature of an infection.  Thus,  Webster and 
Hughes (5)  concluded that  the numbers and  degree of infection of 
pneumococcus carriers varied directly with the  incidence of  coryza, 
sore throat and other respiratory tract diseases.  They thought that 
pneumococcus carriers are infected individuals with organisms growing 
in  their  nasopharyngeal tissues,  and  further that  the  presence or 
absence of the carrier state depended on the resistance of the host, a 
factor which varied with the season of year.  Bull  and  McKee  (8) 
had  shown  that a  certain number of rabbits which gave no sign  of 
infection following  intranasal  instillation of pneumococci developed 
protective antibodies and that their serum contained agglutinins and 
fixed complement.  Neufeld and  Tulczynska (9)  also  were  able  to 
show that  mice inoculated intranasally with  pneumococci and  be- 
coming carriers acquired an immunity which was higher the longer 
the carrier state persisted.  They thought that the immunity might 
be  due  to  passage  of a  few organisms through  the  nasal  mucosa, 
the absorptive  capabilities  of  which  were considered  to  be  very 
good.  The latter assumptions have been shown elsewhere to be true 
(10). 
Studies of pneumococcus carriers (5)  and meningococcus carriers 
(1) in an unselected group of individuals who had had no known con- 
tact with the frank disease have shown a striking similarity to exist 
between the two conditions.  It was therefore obviously necessary 
to  examine the  meningococcus carrier state  carefully to determine 
whether this is to be regarded as an infection or not. 
A study of coryza, pharyngitis and upper respiratory disease in a 
group of non-contact carriers (1)  and in the carriers at Camp Rusk 
has failed to reveal any direct relationship between these inflammatory 
conditions and the duration or extent of the carrier state.  Indeed, 
the only possible relationship, and this was little more than suggested, 
was that any infection accompanied by the copious outgrowth of a 
pathogen,  such as Hemophilus influenzae or pneumococcus, caused 
the numbers of meningococci to decrease. 
Attention was therefore paid to the reactions of the serum in known 
meningococcus carriers.  Serum  was  obtained  from  41  carriers  of 
which 31  were Type I  and  10  Type II.  Serum was also obtained 
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both  intravenous  and  intrathecal.  In  every  case  the  serum  was 
tested for the presence of agglutinins and in the case of 12 Type I and 
5  Type  II  sera  and  also  sera from 4  recovered  cases,  tests were 
made for the presence of protective antibodies. 
The agglutination tests were set up in a 37°C. water bath and then 
allowed to stand overnight in the ice box.  The  serum  was  tested 
against freshly isolated and readily agglutinable Type I  and Type II 
strains  at  final serum dilutions of  1/10,  1/20  and  1/40.  Of the 31 
Type I sera, 21 gave no agglutination or one that was slight and equal 
with both Type I  and Type 1I organisms, 6 gave moderate agglutina, 
tion to 1/20 without any cross-agglutination or even slightly to 1/40 
TABLE  III 
Good 
Moderate 
None 
Agglutination  Protection 
Type I  Type II  Type I  Type II 
13, 58, 73, 95 
7, 45, 55, 67, 75,  167 
2,  15,  16,  32, 40,  52,  66, 74, 
79,  115  e,  124,  127,  132, 
138,  145,  149,  152,  153, 
185, 194, 198 
57, 139 
24, 54,141,207 
38,  85,  115  d, 
169 
7, 55, 58 
67,  73,  138, 
167,185 
13,  75,  95, 
194 
24, 54 
85,  115  d, 
207 
and 4 gave good agglutination out to 1/40.  Of the 10 Type II sera, 
4  gave no agglutination or one that was slight and equal with both 
Type I  and Type II organisms, 4 gave a moderate agglutination and 
2  gave good agglutination  (Table  III).  21  sera  from  normal  in- 
dlviduals or from persons suffering from epidemic encephalitis failed 
to agglutinate either Type I or Type II organisms under the conditions 
of the experiment. 
In  the protection  tests  use  was made of the virulence test  with 
mucin suspensions  as outlined above.  0.2  cc.  of  the  serum  to  be 
tested was injected intraperitoneally into white-face mice 30 minutes 
to  1 hour before inoculation of the mucin suspension of organisms. 
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ranging  from  10  -2 to  10  -~ of the standard  suspension  (2,000,000,000 
per cc.) using 2 mice at  each dilution.  Control tests were made at 
the same time that a batch of sera from carriers was tested and con- 
sisted of a test without any serum, one with presumably normal pooled 
human serum  s and a third with Type I  or Type II antimeningococcal 
horse serum of known protective potency. 
Since 2 cc. of serum was the minimum required for each protection 
test even when  tested only against  organisms  homologous with  the 
type carried in the throat of the individual from whom the serum was 
obtained, only a limited number of the sera collected could be te~ted. 
In all, 3  experiments were made and 12 sera from Type I  carriers and 
5  from  Type  II  carriers  were  tested.  The  results  are  shown  in 
Table IV. 
From  an  examination  of Table  IV it will be seen  that  3  Type I 
carrier sera and 2 Type II give good protection, 5 Type I  sera give a 
certain  amount  of protection  as  compared  with  the  controls  and  4 
Type I  and  3  Type II sera give no protection.  In Table III these 
sera  are  shown  ranged  according  to  whether  their  protection  was 
good, moderate or high,  and compared with the agglutination  of the 
same  and  other  carrier  sera  also  arranged  in  3  somewhat  arbitrary 
groups.  It  is  obvious that  the  correspondence  between  content  of 
agglutinins  and content of protective antibodies as demonstrated by 
these tests is not close.  Of the 17 sera with which both agglutination 
and  protection  tests  were done,  11  showed some correspondence  in 
containing both agglutinins and protective antibodies, while 6 showed 
no correspondence. 
Nine sera from recovered cases were obtained.  Of these only one 
(No.  X)  had  not  received  treatment  with  antimeningococcal  poly- 
valent  serum.  This  serum  gave  a  moderate  agglutination  against 
Type II meningococci and good protection against Type II organisms. 
No strain  had  ever been isolated from this case but the spinal fluid 
drawn at the height of the disease gave a moderately strong precipitin 
3 Owing to the limited number of white-face mice available, it was not possible 
to perform protection  tests with large numbers of normal human  sera.  Under 
these circumstances it was decided to pool 4 normal sera and use this as a control 
in each protection test.  Since  4 different sera were used with each test, 12 control 
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reaction with Type II monovalent serum.  In the 8  cases in which 
serum therapy had been administered 1 to 4 months before blood was 
drawn for testing, 6  (Nos. 30, 81 b, 106, 154, Y, Z) showed no agglu- 
TABLE  IV 
Serum No. 
73 
No serum 
Pooled normal 
serum 
Immune Type 
I serum 
7 
1 67  138 
/167 
~185 
(,3 
75 
No serum 
Normal pooled 
serum 
Immune Type 
I  serum 
Type  I  Type II 
10_..~_  ~  I0-._~  4  __10 
1, 1  1, 
1,  1, 
1,  1,  2, 
1,2  1,1  2, 
2,2  1,2  1, 
1, 1  2,2  1, 
1,2  1, 1  2, 
No deaths 
No deaths 
lO-e 
1,3 
1,2 
1, 
2, 
2, 2 
Serum  No. 
1 85  115 d 
~207 
No serum 
Pooled  nor- 
mal serum 
Immune 
10  ~  lO-S  10  ~  10-6  10"-6 
No deaths 
t 1,1  3, 
1, 1  1,  1, 
1, 1  1,  .~ 
1,2  2,2  2,  1, 
1,2  1,2 
1, 
1,1  1,1 
1,  1,2 
1,1  1,1 
1,1  1,1 
1, 1  1, 
1,1  1,1 
1,1  1,1 
1,2  1,2 
2, 
i  1, 
1, 
1,2  1,2 
1,  2, 
[ 1, 2  2,  b~ 
L  2,2  2, 
L 
No deaths 
Type  II 
serum 
e~ 
Figures indicate  duration  of  life in days  (i.e.,  2  -  died during 2nd day).  2 
mice were tested in each dilution; blank indicates mouse survived. 
tinins and 2  (Nos.  35  and V)  showed good agglutinins for Type II 
organisms.  Of these latter 2, No. 35 had received serum therapy 3-~ 
months before being bled and the other was considerably more recent, G~O~F~Y ~r~  557 
having received both intrathecal and intravenous serum only 3 weeks 
before.  In the case of 3 of the 8 sera (Nos. 30, 81 b and Y) protection 
tests were made.  All 3  showed moderate protection.  No.  30  had 
received serum 4 months before, No. 81 b  1 month before and Y  2 
months before. 
It seems clear from these results on the carrier sera that there is, in 
a  certain percentage of cases,  some general reaction of the body, at 
least serological,  to the presence of meningococci in the nasopharynx. 
Thus, 32.3 per cent of Type I  carrier sera tested and 60 per cent of 
Type II sera tested showed moderate or good agglutinins for homol- 
ogous organisms.  Also 80 per cent of Type I sera tested'and 40 per 
cent of Type II sera tested showed moderate or good protective anti- 
bodies against homologous organisms. 
Despite the absence of any convincing local infection in meningo- 
coccus carriers, this general reaction of the body would seem to point 
to the fact that the carrier state is to be looked upon as an infection. 
It seems probable that small numbers of meningococci are continually 
making their way  through  the  mucosa and  that  these organisms, 
entering the local tissues and also the blood and lymph streams, are 
sufficient to produce immune reactions.  Such is known to be the case 
with experimental pneumococcus infections in animals (8, 10). 
It was unfortunately quite impossible to obtain any idea in these 
individuals as to how long the carrier state had existed.  It can only 
be said that for the great majority it probably was not over 9 months, 
the length of time the camp had been in existence, and that for many 
it was probably not more than 4½ months, which was the time since 
the first case appeared in the camp and the time at which date the 
carrier rate probably first greatly exceeded 20 per cent. 
S~ARY  AND  CONCLUSIONS 
The investigation of this isolated epidemic of meningococcus  men- 
ingitis at a C.C.C. camp gave  an opportunity to examine the carrier 
state in contacts carrying what were presumably virulent epidemic 
strains of organisms. 
With  the  aid  of  Miller's  technique for  the  enhancement of  the 
demonstrable virulence of meningococci for mice, it proved possible 
to test the virulence of the carrier strains from Camp Rusk.  These 558  M~ENINGOCOCCUS INFECTION.  VII 
results were consistent despite the interval of from 3 to 4 weeks which 
intervened between the isolation of the strains and the virulence titra- 
tions.  Type I  strains were found to have a high virulence, while the 
virulence of Type II strains was moderately high but definitely less 
than that of the Type I, and atypical strains and strains of N. catar- 
rhalis isolated from carriers showed a very low virulence. 
The question of the precise nature of the carrier state was inves- 
tigated.  No evidence has been obtained yet as to the existence of a 
relationship between pharyngitis, coryza or upper respiratory disease 
and the presence and degree of the carrier state.  This is unlike the 
situation with regard to pneumococcus carriers.  On the other hand, 
it has proved possible to demonstrate reactions within the body to 
the meningococci in the nasopharynx, consisting of the formation of 
agglutinins and protective antibodies in the blood serum.  32.3  per 
cent of Type I and 60 per cent of Type II carrier sera showed moderate 
or good agglutinins for homologous  organisms and 80 per cent of Type 
I and 40 per cent of Type II sera showed moderate or good protective 
antibodies  against  virulent homologous strains.  No  idea  could be 
obtained as  to  the relationship of the presence or  absence and the 
degree of serological reaction and the duration of the carrier state. 
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